Lipoprotein(a) distributions and trial eligibility thresholds for Lp(a)-lowering therapies in the general population: The Rotterdam Study
European Journal of Preventive Cardiology
- Lipid and ceramide metabolism
- Lipoprotein
- LPA
- Aortic valve calcification score
- Aortic valve stenosis
- Humans
The paper
Gaia Hermans, Daniël Bos, Maryam Kavousi, Maarten J.G. Leening
Show 4 more authors
M. Arfan Ikram, Eric J.G. Sijbrands, Frank J. Wolters, Jeanine E. Roeters van Lennep,Erasmus MC
European Journal of Preventive Cardiology · 31 Aug 2026
